Takayuki Kikuchi

Apr 11, 2024 | cienciaysaludnatural.com | Miki Gibo |Seiji Kojima |Akinori Fujisawa |Takayuki Kikuchi

Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan DOI: 10.7759/cureus.57860 – https://www.cureus.com/articles/196275-increased-age-adjusted-cancer-mortality-after-the-third-mrna-lipid-nanoparticle-vaccine-dose-during-the-covid-19-pandemic-in-japan#!/ El médico epidemiólogo Miki Gibo, afiliado a la Clínica Matsubara y al Hospital Yusuhara del Seguro Nacional de Salud en Yusuhara, Kochi, Japón, y sus colegas...

Apr 8, 2024 | cureus.com | Miki Gibo |Seiji Kojima |Akinori Fujisawa |Takayuki Kikuchi

SpecialtyPlease chooseI'm not a medical professional. Allergy and ImmunologyAnatomyAnesthesiologyCardiac/Thoracic/Vascular SurgeryCardiologyCritical CareDentistryDermatologyDiabetes and EndocrinologyEmergency MedicineEpidemiology and Public HealthFamily MedicineForensic MedicineGastroenterologyGeneral PracticeGeneticsGeriatricsHealth PolicyHematologyHIV/AIDSHospital-based MedicineI'm not a medical professional.

Jan 28, 2024 | onlinelibrary.wiley.com | Chenhui Wang |Nobuyuki Sakai |Yasuo Ebina |Takayuki Kikuchi

1 Introduction Soft-chemical process of delaminating/exfoliating layered materials into unilamellar nanosheets dispersed in solution and reassembling them as building blocks is one of the most effective approaches for designing and fabricating advanced nanostructured materials with desired functionality.[1-6] The tailored structures and specific properties associated with them can be constructed by precisely controlling the arrangements of selected nanosheets or other components at a...

Aug 17, 2023 | jnis.bmj.com | Ryo Akiyama |Akira Ishii |Takayuki Kikuchi |Masakazu Okawa

DiscussionTo the best of our knowledge, this is the largest series to investigate outcomes after flow diversion treatment in patients with internal carotid artery aneurysms presenting with cranial neuropathy. In addition, no previous study has reported detailed long-term follow-up of symptoms in these patients in a real-world clinical setting. In our study, as in a previous report,11 the proportion of patients whose symptoms resolved or improved increased over the first 12 months.